Author Information
Michael Thomas Lotze is an esteemed researcher affiliated with the Department of Surgery, Department of Immunology, and Department of Bioengineering at the University of Pittsburgh, Pittsburgh, PA, United States. His extensive work spans multiple facets of cancer research, with a notable focus on immunotherapy, tumor microenvironments, and computational modeling of cancer cell signaling.Research Contributions
Michael Thomas Lotze has made significant contributions to the field of oncology, particularly in the context of breast and pancreatic cancer. His research encompasses the development of personalized therapies for breast cancer, exploring the role of tumor-associated macrophages, and innovating immune-based treatments for colorectal cancer. His work also delves into computational modeling to understand cancer cell signaling and mutations, as well as identifying molecular markers that predict treatment responses. His studies have been pivotal in advancing the understanding of cancer biology and improving therapeutic strategies.Aliases
Michael Thomas Lotze is known by several aliases in the academic and research community, including M T. Lotze, Michael T. Lotze, Michael\u2004t. Lotze, Mike Lotze, M Lotze, M. T. Lotze, M T Lotze, and M. Lotze.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
60,762 |
| h-index |
121 |
| Paper Count |
693 |
